Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Antibe update

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Dec 01, 2020 5:43pm

90 Views

Post# 32014731

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Antibe update

The big question is so what?

One day you will be happy that this stock isn't tied to the market's actions and reactions.
That's the beauty of drug marketing ... if they get it right.
That's the reason I'm here.

That's a ways off Benny.

There is absolutely no clear messeage to MNGT - remember that.
That means nothing here ... simply fiction.

You can laugh at that comment ... but remember who said it and who stuck by it.

: )

<< Previous

Bullboard Posts

Next >>

How does sponsorship affect share price?